Academic Progress-BIOTECH PHARMACEUTICAL CO., LTD_EGF Vaccine_ Nimotuzumab

BIOTECH

Home
About Us
About Us

BPL is a high-tech China-Cuba joint venture among first group engaged in the development, production and sales of monoclonal antibodies in China.
S&T
S&T

International-standard humanized monoclonal antibody preparation processes and large-scale, continuous mammalian cell culture technology.
- Research Areas
- Technology Platforms
Research and Development
Research and Development

China has developed nivolumab, a humanized monoclonal antibody drug (trade name: TaiXinSheng), for the treatment of malignant tumors.
Blog
Blog

Integrating industry-related media coverage as well as the company’s various activities and updates.
- Company News
- Media Reports
Join Us
Join Us

Boasting a postdoctoral research workstation and diverse career opportunities, we sincerely invite talented individuals from all fields to join Baite.
- Post-Doctoral Center
Contact Us
Contact Us

ThaiXinLife Consultation Hotline: +86 4006592330
Company Main Line: +86-10-51571020
- Contact Us

Image Name

Marketed Products

Academic Progress

[Case Study] Issue 228: A Case of Advanced Pancreatic Cancer Treated with Nilotinib Combined with Gemcitabine in a Prolonged Treatment Cycle

[Case Study] Issue 228: A Case of Advanced Pancreatic Cancer Treated with Nilotinib Combined with Gemcitabine in a Prolonged Treatment Cycle

[Case Study] Issue 228: A Case of Advanced Pancreatic Cancer Treated with Nilotinib Combined with Gemcitabine in a Prolonged Treatment Cycle

[Case Report] Issue 227: Diagnosis and Treatment Process of a Cervical Squamous Cell Carcinoma Recurrence After Surgery, Radiotherapy, and Chemotherapy, Treated with Nimotuzumab

[Case Report] Issue 227: Diagnosis and Treatment Process of a Cervical Squamous Cell Carcinoma Recurrence After Surgery, Radiotherapy, and Chemotherapy, Treated with Nimotuzumab

[Case Report] Issue 227: Diagnosis and Treatment Process of a Cervical Squamous Cell Carcinoma Recurrence After Surgery, Radiotherapy, and Chemotherapy, Treated with Nimotuzumab

[Case Study] Issue 226: Nilotinib Plus Induction Chemotherapy Followed by Concurrent Radiotherapy for Locally Advanced Nasopharyngeal Cancer

[Case Study] Issue 226: Nilotinib Plus Induction Chemotherapy Followed by Concurrent Radiotherapy for Locally Advanced Nasopharyngeal Cancer

[Case Study] Issue 226: Nilotinib Plus Induction Chemotherapy Followed by Concurrent Radiotherapy for Locally Advanced Nasopharyngeal Cancer

[ShengSheng Case Study] Issue 225: Nilotinib Combined with Radiotherapy for the Treatment of Laryngeal Cancer

[ShengSheng Case Study] Issue 225: Nilotinib Combined with Radiotherapy for the Treatment of Laryngeal Cancer

[ShengSheng Case Study] Issue 225: Nilotinib Combined with Radiotherapy for the Treatment of Laryngeal Cancer

[Shengxin Case] Issue 224: Nilotinib Treatment Case for Pancreatic Cancer

[Shengxin Case] Issue 224: Nilotinib Treatment Case for Pancreatic Cancer

[Shengxin Case] Issue 224: Nilotinib Treatment Case for Pancreatic Cancer

[Case Report] Issue 223: Exploring Nivolumab in the Treatment of Stage IIIC1r Cervical Adenosquamous Carcinoma
[Link: https://mp.weixin.qq.com/s/XvptDYmeQaVjk-FoDtlH8A]

[Case Report] Issue 223: Exploring Nivolumab in the Treatment of Stage IIIC1r Cervical Adenosquamous Carcinoma [Link: https://mp.weixin.qq.com/s/XvptDYmeQaVjk-FoDtlH8A]

[Case Report] Issue 223: Exploring Nivolumab in the Treatment of Stage IIIC1r Cervical Adenosquamous Carcinoma [Link: https://mp.weixin.qq.com/s/XvptDYmeQaVjk-FoDtlH8A]

< 1...30 31 32...88 >

Biotech pharmaceutical co., Ltd

Tel: +86-400-659-2330

Exchange Tel: +86-10-51571020

Email: cooperation@biotechplc.com

BD Dept: bd@biotechplc.com

Image Name

Address：NO.2 Rongjing East Street, Beijing Economic and Technological Development Area, Beijing 100176

Biotech pharmaceutical co., Ltd

互联网药品信息编号：(京)非经营性2016-0046

Powered by：CEglobal

Business License

中企跨境-全域组件 1.92 制作前进入CSS配置样式

导航下拉添加类名.active

在线客服添加返回顶部

右侧在线客服样式 1,2,3 1

图片alt标题设置： BIOTECH PHARMACEUTICAL CO., LTD

表单验证提示文本： Content cannot be empty!

循环体没有内容时： Sorry, no matching items were found.

CSS / JS 文件放置地